Leading Hospital Network to Invest Rs 250 Crore in Cutting-Edge Oncology Centre with India’s First Proton Therapy System
Leading Hospital Network to Invest Rs 250 Crore in Cutting-Edge Oncology Centre with India’s First Proton Therapy System

Leading Hospital Network to Invest Rs 250 Crore in Cutting-Edge Oncology Centre with India’s First Proton Therapy System

The proposed oncology centre, to be established in Hyderabad by FY 2028, aims to enhance access to Proton Beam Therapy, a state-of-the-art cancer treatment.

DSIJ Intelligence Article rating: 3.5

The company is also progressing on its expansion strategy, aiming to add 3,512 beds over the next 3 to 4 years, starting from FY26.

305 Per Cent Returns: Leading Hospital Chain Delivers 51.8 Per Cent PAT Growth; Stock Down 6.61 Per Cent
305 Per Cent Returns: Leading Hospital Chain Delivers 51.8 Per Cent PAT Growth; Stock Down 6.61 Per Cent

305 Per Cent Returns: Leading Hospital Chain Delivers 51.8 Per Cent PAT Growth; Stock Down 6.61 Per Cent

Net profit surged 51.8 per cent YoY to Rs 372.3 crore, up from Rs 245.3 crore in the same quarter last year.

DSIJ Intelligence Article rating: 5.0

Revenue from operations increased by 13.9 per cent YoY to Rs 5,526.9 crore, compared to Rs 4,850.6 crore in Q3 FY24.

High Dividend Stock: Shares of this company surged post the announcement of a 120 per cent dividend!
High Dividend Stock: Shares of this company surged post the announcement of a 120 per cent dividend!

High Dividend Stock: Shares of this company surged post the announcement of a 120 per cent dividend!

Shares of the company, one of the top gainers of BSE Healthcare pack, soared over 5 per cent on a more than 6-fold increase in volume!

DSIJ Intelligence Article rating: 4.3

Shares of the company, one of the top gainers of BSE Healthcare pack, soared over 5 per cent on a more than 6-fold increase in volume!

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR